The Global Pharma and Biotech Summit is the essential event for you to explore era-defining trends and developments in ...

Anglo-Swedish pharma major AstraZeneca closed Thursday’s trading 3% higher, as investors digested its third quarter financial ...

South Korea’s Samsung Bioepis. has signed a settlement and license agreement with Johnson & Johnson concerning the ...

US biopharma company Ultragenyx Pharmaceutical today announced the sale, for $400 million, of an additional 25% of the ...

Swiss inflammatory diseases specialist MoonLake Immunotherapeutics has announced the pricing of a $75 million underwritten offering.

Cambridge, USA-based mRNA vaccines company Moderna today reported financial results and provided business updates for the third quarter of 2025 that beat expectations, sending its shares up 7.1% to ...

US mRNA-based therapeutics company Strand Therapeutics has announced the promotion of Prashant Nambiar to chief scientific ...

The Russian government has approved the allocation of 140 billion roubles ($1.72 billion) annually for the treatment of ...

A biotech company developing in-body genome engineering therapies to program a patient’s own T cells directly within the body ...

California, USA-based clinical-stage biotech Braveheart Bio has announced its launch with $185 million in Series A financing, ...

The zero-gravity environment of orbit is emerging as a new frontier for biopharmaceutical innovation. According to GlobalData ...

Arena BioWorks, a privately funded biomedical research institute that aimed to overhaul the traditional drug discovery model, ...